in this issue
Regions :: North America :: U.S.
Chemtura beats estimates, but bromine weakness persists
3:52 PM MDT | July 30, 2013 | Vincent Valk
Chemtura’s second-quarter net income from continuing declined 11% year-on-year (YOY), to $47 million, or 47 cts/share, on sales down 1%, to $735 million, the company says. Adjusted net income declined 25%, to 40 cts/share, but beat analysts’ consensus estimate of 37 cts/share, as reported by Thomson Reuters. Chemtura recorded an overall net loss, of $93 million, due to a $146 million loss related to the sale of its antioxidants business. Results were mostly in line with Chemtura’s reported preliminary results, issued earlier this month...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee